SavedAdd your journal

Journals / Ulusal Romatoloji Dergisi / 2021 / Cilt: 13 - Sayı: 1

Systemic sclerosis and pulmonary hypertension

Sistemik skleroz ve pulmoner hipertansiyon

Mustafa Özmen
Sercan Gücenmez
Eda Otman Akat
Pages
29–40
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, up-to-date information on SSc associated PH has been reviewed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary involvement is common in systemic sclerosis (SSc) and is the most common cause of SSc-related deaths.
📊
Key Findings & Data:In particular, the development of pulmonary hypertension (PH) significantly shortens the life span of SSc patients and is fatal if left untreated.
💡
Conclusion & Impact:In this article, up-to-date information on SSc associated PH has been reviewed
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary involvement is common in systemic sclerosis (SSc) and is the most common cause of SSc-related deaths. In particular, the development of pulmonary hypertension (PH) significantly shortens the life span of SSc patients and is fatal if left untreated. Diagnosing PH early and accurately and starting early treatment significantly affects the prognosis of the disease positively. In this article, up-to-date information on SSc associated PH has been reviewed

Özet

Sistemik sklerozda (SSk) akciğer tutulumu sıktır ve SSk ilişkili ölümlerin en sık nedenidir. Özellikle pulmoner hipertansiyon (PH), SSk hastalarının yaşam süresini belirgin olarak kısaltmaktadır ve tedavi edilmediğinde ölümcüldür. PH’yi erken ve doğru tanımak ve tedaviye başlamak, hastalığın seyrini önemli ölçüde olumlu etkilemektedir. Bu yazıda, SSk’de görülen PH hakkındaki güncel bilgiler derlenmişt

🔖

Cite This Article

Özmen, M., Gücenmez, S., Akat, E. O. (2022). Systemic sclerosis and pulmonary hypertension. Ulusal Romatoloji Dergisi, Cilt: 13 - Sayı: 1, 29–40. https://ajindex.com/articles/643879

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390:1685-99
  2. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4
  3. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-22
  4. Almaaitah S, Highland KB, Tonelli AR. Management of Pulmonary arterial hypertension in patients with systemic sclerosis. Integr Blood Press Control 2020;13:15-29
  5. Humbert M, Yaici A, de Groote P, et al. Screening for Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 2011;63:3522-30
  6. Hinchcliff M, Fischer A, Schiopu E, Steen VD. Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 2011;38:2172-9
  7. Hatano S, Strasser T, eds. Primary Pulmonary Hypertension. Report on a WHO Meeting. Geneva, World Health Organization, 1975
  8. World Health Organization. Chronic cor pulmonale. Report of an expert committee. World Health Organ Tech Rep Ser 1961;213:35
  9. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34:888-94
  10. Thomas CA, Anderson RJ, Condon DF, et al. Diagnosis and management of pulmonary hypertension in the modern era: insights from the 6th world symposium. Pulm Ther 2020;6:9-22
  11. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913. doi: 10.1183/13993003.01913-2018
  12. Fayed H, Coghlan JG. Pulmonary Hypertension Associated with Connective Tissue Disease. Semin Respir Crit Care Med 2019;40:173-83
  13. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137:376-87
  14. Yang X, Mardekian J, Sanders KN, Mychaskiw MA, Thomas J 3rd. Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature. Clin Rheumatol 2013;32:1519-31
  15. Coghlan JG, Denton PC, Grünig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014;73:1340-9
  16. Xanthouli P, Jordan S, Milde N